Houston Methodist Hospital (Medical Center) Family Medicine

Topics

• Diabetes Treatment and Management 9
• Pharmacology and Obesity Treatment 9
• Bariatric Surgery and Outcomes 8
• Obesity and Health Practices 8
• Airway Management and Intubation Techniques 2
• Diabetes Management and Education 2
• Diet and metabolism studies 2
• Diversity and Impact of Dance 2
• Health and Lifestyle Studies 2
• Advanced Proteomics Techniques and Applications 1
• Anesthesia and Sedative Agents 1
• Antioxidant Activity and Oxidative Stress 1

Most cited

1. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial.

   JAMA · 2024 · 690 citations · Deborah Horn

2. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.

   The New England journal of medicine · 2025 · 427 citations · Deborah Horn

3. Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial.

   Nature medicine · 2024 · 266 citations · Deborah Horn

4. Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial.

   Lancet (London, England) · 2026 · 36 citations · Deborah Horn

5. Cardiometabolic Parameter Change by Weight Regain on Tirzepatide Withdrawal in Adults With Obesity: A Post Hoc Analysis of the SURMOUNT-4 Trial.

   JAMA internal medicine · 2026 · 24 citations · Deborah Horn

6. Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial.

   Diabetes care · 2024 · 75 citations · Deborah Horn